We support the goals of the
Global Polio Eradication Initiative (GPEI), which aims to treat 50 million people with TB and prevent 14 million deaths from the disease by 2015. Our strategy supports efforts to
Increase the number of polio vaccination campaigns
Mass immunization campaigns that administer oral polio vaccine to every child under 5 are one of the key ways to interrupt the circulation of poliovirus. We support immunization campaigns in the four remaining polio-endemic areas and the other countries that remain at risk.
Create innovative surveillance and control systems
A strong and sensitive surveillance system provides the information needed to ensure that polio resources are accurately targeted, programmatic adjustments are made in a timely and efficient fashion, and outbreaks are identified and addressed as soon as possible. We support reforms of the current global polio surveillance system and the development of new surveillance approaches.
Increase the demand for polio vaccinations among households and communities
Some children not immunized against polio because of their caregivers’ concerns about vaccinations. We support communication strategies to keep families and communities engaged on the importance of polio eradication, address their fears and concerns about immunization, and promote other health behaviors that improve the survival and well-being of children.
Advocate for funding and commitment
Globally, there is a shortage of funding to implement all the activities necessary for polio eradication. We are engaged in efforts to secure additional funds and sustained political commitment so that eradication activities can be carried out when and where they are needed.
Develop new vaccines
Oral polio vaccine, the most widely used vaccine against polio, is highly effective. However, in extremely rare instances, the vaccine can cause neurological damage and the weakened poliovirus used in the vaccine can adapt and mutate into a deadlier version that causes polio in the very children it was meant to protect. We are supporting efforts to develop better vaccines that address these challenges.
Develop antiviral drugs
Antiviral drugs are needed in the case of a future accidental or intentional reintroduction of poliovirus in the post-eradication era. We’re supporting investments to identify at least two inexpensive, stable, orally administered antiviral drugs that are safe for individuals of all ages and effective against all poliovirus types and strains.